Medical Care
Global Still's Disease Treatment Market Research Report 2025
- Mar 11, 25
- ID: 9320
- Pages: 82
- Figures: 88
- Views: 17
The global market for Still's Disease Treatment was valued at US$ 1884 million in the year 2024 and is projected to reach a revised size of US$ 2625 million by 2031, growing at a CAGR of 4.9% during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Still's Disease Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Still's Disease Treatment.
The Still's Disease Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Still's Disease Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Still's Disease Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Biocon Limited
Epirus Biopharmaceuticals, Inc.
Genor BioPharma Co., Ltd.
Hetero Drugs Limited
Mabion SA
Mycenax Biotech Inc.
Oncobiologics, Inc.
Oncodesign SA
Panacea Biotec Limited
Pfizer Inc.
Sandoz International GmbH
Swedish Orphan Biovitrum AB
Therapeutic Proteins International, LLC
UCB S.A.
Segment by Type
Certolizumab Pegol
DNX-514
Etanercept
Others
Segment by Application
Clinic
Hospital
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Still's Disease Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Still's Disease Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Still's Disease Treatment.
The Still's Disease Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Still's Disease Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Still's Disease Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Biocon Limited
Epirus Biopharmaceuticals, Inc.
Genor BioPharma Co., Ltd.
Hetero Drugs Limited
Mabion SA
Mycenax Biotech Inc.
Oncobiologics, Inc.
Oncodesign SA
Panacea Biotec Limited
Pfizer Inc.
Sandoz International GmbH
Swedish Orphan Biovitrum AB
Therapeutic Proteins International, LLC
UCB S.A.
Segment by Type
Certolizumab Pegol
DNX-514
Etanercept
Others
Segment by Application
Clinic
Hospital
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Still's Disease Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Still's Disease Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Certolizumab Pegol
1.2.3 DNX-514
1.2.4 Etanercept
1.2.5 Others
1.3 Market by Application
1.3.1 Global Still's Disease Treatment Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Still's Disease Treatment Market Perspective (2020-2031)
2.2 Global Still's Disease Treatment Growth Trends by Region
2.2.1 Global Still's Disease Treatment Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Still's Disease Treatment Historic Market Size by Region (2020-2025)
2.2.3 Still's Disease Treatment Forecasted Market Size by Region (2026-2031)
2.3 Still's Disease Treatment Market Dynamics
2.3.1 Still's Disease Treatment Industry Trends
2.3.2 Still's Disease Treatment Market Drivers
2.3.3 Still's Disease Treatment Market Challenges
2.3.4 Still's Disease Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Still's Disease Treatment Players by Revenue
3.1.1 Global Top Still's Disease Treatment Players by Revenue (2020-2025)
3.1.2 Global Still's Disease Treatment Revenue Market Share by Players (2020-2025)
3.2 Global Still's Disease Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Still's Disease Treatment Revenue
3.4 Global Still's Disease Treatment Market Concentration Ratio
3.4.1 Global Still's Disease Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Still's Disease Treatment Revenue in 2024
3.5 Global Key Players of Still's Disease Treatment Head office and Area Served
3.6 Global Key Players of Still's Disease Treatment, Product and Application
3.7 Global Key Players of Still's Disease Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Still's Disease Treatment Breakdown Data by Type
4.1 Global Still's Disease Treatment Historic Market Size by Type (2020-2025)
4.2 Global Still's Disease Treatment Forecasted Market Size by Type (2026-2031)
5 Still's Disease Treatment Breakdown Data by Application
5.1 Global Still's Disease Treatment Historic Market Size by Application (2020-2025)
5.2 Global Still's Disease Treatment Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Still's Disease Treatment Market Size (2020-2031)
6.2 North America Still's Disease Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Still's Disease Treatment Market Size by Country (2020-2025)
6.4 North America Still's Disease Treatment Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Still's Disease Treatment Market Size (2020-2031)
7.2 Europe Still's Disease Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Still's Disease Treatment Market Size by Country (2020-2025)
7.4 Europe Still's Disease Treatment Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Still's Disease Treatment Market Size (2020-2031)
8.2 Asia-Pacific Still's Disease Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Still's Disease Treatment Market Size by Region (2020-2025)
8.4 Asia-Pacific Still's Disease Treatment Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Still's Disease Treatment Market Size (2020-2031)
9.2 Latin America Still's Disease Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Still's Disease Treatment Market Size by Country (2020-2025)
9.4 Latin America Still's Disease Treatment Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Still's Disease Treatment Market Size (2020-2031)
10.2 Middle East & Africa Still's Disease Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Still's Disease Treatment Market Size by Country (2020-2025)
10.4 Middle East & Africa Still's Disease Treatment Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Biocon Limited
11.1.1 Biocon Limited Company Details
11.1.2 Biocon Limited Business Overview
11.1.3 Biocon Limited Still's Disease Treatment Introduction
11.1.4 Biocon Limited Revenue in Still's Disease Treatment Business (2020-2025)
11.1.5 Biocon Limited Recent Development
11.2 Epirus Biopharmaceuticals, Inc.
11.2.1 Epirus Biopharmaceuticals, Inc. Company Details
11.2.2 Epirus Biopharmaceuticals, Inc. Business Overview
11.2.3 Epirus Biopharmaceuticals, Inc. Still's Disease Treatment Introduction
11.2.4 Epirus Biopharmaceuticals, Inc. Revenue in Still's Disease Treatment Business (2020-2025)
11.2.5 Epirus Biopharmaceuticals, Inc. Recent Development
11.3 Genor BioPharma Co., Ltd.
11.3.1 Genor BioPharma Co., Ltd. Company Details
11.3.2 Genor BioPharma Co., Ltd. Business Overview
11.3.3 Genor BioPharma Co., Ltd. Still's Disease Treatment Introduction
11.3.4 Genor BioPharma Co., Ltd. Revenue in Still's Disease Treatment Business (2020-2025)
11.3.5 Genor BioPharma Co., Ltd. Recent Development
11.4 Hetero Drugs Limited
11.4.1 Hetero Drugs Limited Company Details
11.4.2 Hetero Drugs Limited Business Overview
11.4.3 Hetero Drugs Limited Still's Disease Treatment Introduction
11.4.4 Hetero Drugs Limited Revenue in Still's Disease Treatment Business (2020-2025)
11.4.5 Hetero Drugs Limited Recent Development
11.5 Mabion SA
11.5.1 Mabion SA Company Details
11.5.2 Mabion SA Business Overview
11.5.3 Mabion SA Still's Disease Treatment Introduction
11.5.4 Mabion SA Revenue in Still's Disease Treatment Business (2020-2025)
11.5.5 Mabion SA Recent Development
11.6 Mycenax Biotech Inc.
11.6.1 Mycenax Biotech Inc. Company Details
11.6.2 Mycenax Biotech Inc. Business Overview
11.6.3 Mycenax Biotech Inc. Still's Disease Treatment Introduction
11.6.4 Mycenax Biotech Inc. Revenue in Still's Disease Treatment Business (2020-2025)
11.6.5 Mycenax Biotech Inc. Recent Development
11.7 Oncobiologics, Inc.
11.7.1 Oncobiologics, Inc. Company Details
11.7.2 Oncobiologics, Inc. Business Overview
11.7.3 Oncobiologics, Inc. Still's Disease Treatment Introduction
11.7.4 Oncobiologics, Inc. Revenue in Still's Disease Treatment Business (2020-2025)
11.7.5 Oncobiologics, Inc. Recent Development
11.8 Oncodesign SA
11.8.1 Oncodesign SA Company Details
11.8.2 Oncodesign SA Business Overview
11.8.3 Oncodesign SA Still's Disease Treatment Introduction
11.8.4 Oncodesign SA Revenue in Still's Disease Treatment Business (2020-2025)
11.8.5 Oncodesign SA Recent Development
11.9 Panacea Biotec Limited
11.9.1 Panacea Biotec Limited Company Details
11.9.2 Panacea Biotec Limited Business Overview
11.9.3 Panacea Biotec Limited Still's Disease Treatment Introduction
11.9.4 Panacea Biotec Limited Revenue in Still's Disease Treatment Business (2020-2025)
11.9.5 Panacea Biotec Limited Recent Development
11.10 Pfizer Inc.
11.10.1 Pfizer Inc. Company Details
11.10.2 Pfizer Inc. Business Overview
11.10.3 Pfizer Inc. Still's Disease Treatment Introduction
11.10.4 Pfizer Inc. Revenue in Still's Disease Treatment Business (2020-2025)
11.10.5 Pfizer Inc. Recent Development
11.11 Sandoz International GmbH
11.11.1 Sandoz International GmbH Company Details
11.11.2 Sandoz International GmbH Business Overview
11.11.3 Sandoz International GmbH Still's Disease Treatment Introduction
11.11.4 Sandoz International GmbH Revenue in Still's Disease Treatment Business (2020-2025)
11.11.5 Sandoz International GmbH Recent Development
11.12 Swedish Orphan Biovitrum AB
11.12.1 Swedish Orphan Biovitrum AB Company Details
11.12.2 Swedish Orphan Biovitrum AB Business Overview
11.12.3 Swedish Orphan Biovitrum AB Still's Disease Treatment Introduction
11.12.4 Swedish Orphan Biovitrum AB Revenue in Still's Disease Treatment Business (2020-2025)
11.12.5 Swedish Orphan Biovitrum AB Recent Development
11.13 Therapeutic Proteins International, LLC
11.13.1 Therapeutic Proteins International, LLC Company Details
11.13.2 Therapeutic Proteins International, LLC Business Overview
11.13.3 Therapeutic Proteins International, LLC Still's Disease Treatment Introduction
11.13.4 Therapeutic Proteins International, LLC Revenue in Still's Disease Treatment Business (2020-2025)
11.13.5 Therapeutic Proteins International, LLC Recent Development
11.14 UCB S.A.
11.14.1 UCB S.A. Company Details
11.14.2 UCB S.A. Business Overview
11.14.3 UCB S.A. Still's Disease Treatment Introduction
11.14.4 UCB S.A. Revenue in Still's Disease Treatment Business (2020-2025)
11.14.5 UCB S.A. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Still's Disease Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Certolizumab Pegol
1.2.3 DNX-514
1.2.4 Etanercept
1.2.5 Others
1.3 Market by Application
1.3.1 Global Still's Disease Treatment Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Still's Disease Treatment Market Perspective (2020-2031)
2.2 Global Still's Disease Treatment Growth Trends by Region
2.2.1 Global Still's Disease Treatment Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Still's Disease Treatment Historic Market Size by Region (2020-2025)
2.2.3 Still's Disease Treatment Forecasted Market Size by Region (2026-2031)
2.3 Still's Disease Treatment Market Dynamics
2.3.1 Still's Disease Treatment Industry Trends
2.3.2 Still's Disease Treatment Market Drivers
2.3.3 Still's Disease Treatment Market Challenges
2.3.4 Still's Disease Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Still's Disease Treatment Players by Revenue
3.1.1 Global Top Still's Disease Treatment Players by Revenue (2020-2025)
3.1.2 Global Still's Disease Treatment Revenue Market Share by Players (2020-2025)
3.2 Global Still's Disease Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Still's Disease Treatment Revenue
3.4 Global Still's Disease Treatment Market Concentration Ratio
3.4.1 Global Still's Disease Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Still's Disease Treatment Revenue in 2024
3.5 Global Key Players of Still's Disease Treatment Head office and Area Served
3.6 Global Key Players of Still's Disease Treatment, Product and Application
3.7 Global Key Players of Still's Disease Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Still's Disease Treatment Breakdown Data by Type
4.1 Global Still's Disease Treatment Historic Market Size by Type (2020-2025)
4.2 Global Still's Disease Treatment Forecasted Market Size by Type (2026-2031)
5 Still's Disease Treatment Breakdown Data by Application
5.1 Global Still's Disease Treatment Historic Market Size by Application (2020-2025)
5.2 Global Still's Disease Treatment Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Still's Disease Treatment Market Size (2020-2031)
6.2 North America Still's Disease Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Still's Disease Treatment Market Size by Country (2020-2025)
6.4 North America Still's Disease Treatment Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Still's Disease Treatment Market Size (2020-2031)
7.2 Europe Still's Disease Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Still's Disease Treatment Market Size by Country (2020-2025)
7.4 Europe Still's Disease Treatment Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Still's Disease Treatment Market Size (2020-2031)
8.2 Asia-Pacific Still's Disease Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Still's Disease Treatment Market Size by Region (2020-2025)
8.4 Asia-Pacific Still's Disease Treatment Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Still's Disease Treatment Market Size (2020-2031)
9.2 Latin America Still's Disease Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Still's Disease Treatment Market Size by Country (2020-2025)
9.4 Latin America Still's Disease Treatment Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Still's Disease Treatment Market Size (2020-2031)
10.2 Middle East & Africa Still's Disease Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Still's Disease Treatment Market Size by Country (2020-2025)
10.4 Middle East & Africa Still's Disease Treatment Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Biocon Limited
11.1.1 Biocon Limited Company Details
11.1.2 Biocon Limited Business Overview
11.1.3 Biocon Limited Still's Disease Treatment Introduction
11.1.4 Biocon Limited Revenue in Still's Disease Treatment Business (2020-2025)
11.1.5 Biocon Limited Recent Development
11.2 Epirus Biopharmaceuticals, Inc.
11.2.1 Epirus Biopharmaceuticals, Inc. Company Details
11.2.2 Epirus Biopharmaceuticals, Inc. Business Overview
11.2.3 Epirus Biopharmaceuticals, Inc. Still's Disease Treatment Introduction
11.2.4 Epirus Biopharmaceuticals, Inc. Revenue in Still's Disease Treatment Business (2020-2025)
11.2.5 Epirus Biopharmaceuticals, Inc. Recent Development
11.3 Genor BioPharma Co., Ltd.
11.3.1 Genor BioPharma Co., Ltd. Company Details
11.3.2 Genor BioPharma Co., Ltd. Business Overview
11.3.3 Genor BioPharma Co., Ltd. Still's Disease Treatment Introduction
11.3.4 Genor BioPharma Co., Ltd. Revenue in Still's Disease Treatment Business (2020-2025)
11.3.5 Genor BioPharma Co., Ltd. Recent Development
11.4 Hetero Drugs Limited
11.4.1 Hetero Drugs Limited Company Details
11.4.2 Hetero Drugs Limited Business Overview
11.4.3 Hetero Drugs Limited Still's Disease Treatment Introduction
11.4.4 Hetero Drugs Limited Revenue in Still's Disease Treatment Business (2020-2025)
11.4.5 Hetero Drugs Limited Recent Development
11.5 Mabion SA
11.5.1 Mabion SA Company Details
11.5.2 Mabion SA Business Overview
11.5.3 Mabion SA Still's Disease Treatment Introduction
11.5.4 Mabion SA Revenue in Still's Disease Treatment Business (2020-2025)
11.5.5 Mabion SA Recent Development
11.6 Mycenax Biotech Inc.
11.6.1 Mycenax Biotech Inc. Company Details
11.6.2 Mycenax Biotech Inc. Business Overview
11.6.3 Mycenax Biotech Inc. Still's Disease Treatment Introduction
11.6.4 Mycenax Biotech Inc. Revenue in Still's Disease Treatment Business (2020-2025)
11.6.5 Mycenax Biotech Inc. Recent Development
11.7 Oncobiologics, Inc.
11.7.1 Oncobiologics, Inc. Company Details
11.7.2 Oncobiologics, Inc. Business Overview
11.7.3 Oncobiologics, Inc. Still's Disease Treatment Introduction
11.7.4 Oncobiologics, Inc. Revenue in Still's Disease Treatment Business (2020-2025)
11.7.5 Oncobiologics, Inc. Recent Development
11.8 Oncodesign SA
11.8.1 Oncodesign SA Company Details
11.8.2 Oncodesign SA Business Overview
11.8.3 Oncodesign SA Still's Disease Treatment Introduction
11.8.4 Oncodesign SA Revenue in Still's Disease Treatment Business (2020-2025)
11.8.5 Oncodesign SA Recent Development
11.9 Panacea Biotec Limited
11.9.1 Panacea Biotec Limited Company Details
11.9.2 Panacea Biotec Limited Business Overview
11.9.3 Panacea Biotec Limited Still's Disease Treatment Introduction
11.9.4 Panacea Biotec Limited Revenue in Still's Disease Treatment Business (2020-2025)
11.9.5 Panacea Biotec Limited Recent Development
11.10 Pfizer Inc.
11.10.1 Pfizer Inc. Company Details
11.10.2 Pfizer Inc. Business Overview
11.10.3 Pfizer Inc. Still's Disease Treatment Introduction
11.10.4 Pfizer Inc. Revenue in Still's Disease Treatment Business (2020-2025)
11.10.5 Pfizer Inc. Recent Development
11.11 Sandoz International GmbH
11.11.1 Sandoz International GmbH Company Details
11.11.2 Sandoz International GmbH Business Overview
11.11.3 Sandoz International GmbH Still's Disease Treatment Introduction
11.11.4 Sandoz International GmbH Revenue in Still's Disease Treatment Business (2020-2025)
11.11.5 Sandoz International GmbH Recent Development
11.12 Swedish Orphan Biovitrum AB
11.12.1 Swedish Orphan Biovitrum AB Company Details
11.12.2 Swedish Orphan Biovitrum AB Business Overview
11.12.3 Swedish Orphan Biovitrum AB Still's Disease Treatment Introduction
11.12.4 Swedish Orphan Biovitrum AB Revenue in Still's Disease Treatment Business (2020-2025)
11.12.5 Swedish Orphan Biovitrum AB Recent Development
11.13 Therapeutic Proteins International, LLC
11.13.1 Therapeutic Proteins International, LLC Company Details
11.13.2 Therapeutic Proteins International, LLC Business Overview
11.13.3 Therapeutic Proteins International, LLC Still's Disease Treatment Introduction
11.13.4 Therapeutic Proteins International, LLC Revenue in Still's Disease Treatment Business (2020-2025)
11.13.5 Therapeutic Proteins International, LLC Recent Development
11.14 UCB S.A.
11.14.1 UCB S.A. Company Details
11.14.2 UCB S.A. Business Overview
11.14.3 UCB S.A. Still's Disease Treatment Introduction
11.14.4 UCB S.A. Revenue in Still's Disease Treatment Business (2020-2025)
11.14.5 UCB S.A. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Still's Disease Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Certolizumab Pegol
Table 3. Key Players of DNX-514
Table 4. Key Players of Etanercept
Table 5. Key Players of Others
Table 6. Global Still's Disease Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Still's Disease Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Still's Disease Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Still's Disease Treatment Market Share by Region (2020-2025)
Table 10. Global Still's Disease Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Still's Disease Treatment Market Share by Region (2026-2031)
Table 12. Still's Disease Treatment Market Trends
Table 13. Still's Disease Treatment Market Drivers
Table 14. Still's Disease Treatment Market Challenges
Table 15. Still's Disease Treatment Market Restraints
Table 16. Global Still's Disease Treatment Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Still's Disease Treatment Market Share by Players (2020-2025)
Table 18. Global Top Still's Disease Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Still's Disease Treatment as of 2024)
Table 19. Ranking of Global Top Still's Disease Treatment Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Still's Disease Treatment Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Still's Disease Treatment, Headquarters and Area Served
Table 22. Global Key Players of Still's Disease Treatment, Product and Application
Table 23. Global Key Players of Still's Disease Treatment, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Still's Disease Treatment Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Still's Disease Treatment Revenue Market Share by Type (2020-2025)
Table 27. Global Still's Disease Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Still's Disease Treatment Revenue Market Share by Type (2026-2031)
Table 29. Global Still's Disease Treatment Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Still's Disease Treatment Revenue Market Share by Application (2020-2025)
Table 31. Global Still's Disease Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Still's Disease Treatment Revenue Market Share by Application (2026-2031)
Table 33. North America Still's Disease Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Still's Disease Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Still's Disease Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Still's Disease Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Still's Disease Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Still's Disease Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Still's Disease Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Still's Disease Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Still's Disease Treatment Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Still's Disease Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Still's Disease Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Still's Disease Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Still's Disease Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Still's Disease Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Still's Disease Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 48. Biocon Limited Company Details
Table 49. Biocon Limited Business Overview
Table 50. Biocon Limited Still's Disease Treatment Product
Table 51. Biocon Limited Revenue in Still's Disease Treatment Business (2020-2025) & (US$ Million)
Table 52. Biocon Limited Recent Development
Table 53. Epirus Biopharmaceuticals, Inc. Company Details
Table 54. Epirus Biopharmaceuticals, Inc. Business Overview
Table 55. Epirus Biopharmaceuticals, Inc. Still's Disease Treatment Product
Table 56. Epirus Biopharmaceuticals, Inc. Revenue in Still's Disease Treatment Business (2020-2025) & (US$ Million)
Table 57. Epirus Biopharmaceuticals, Inc. Recent Development
Table 58. Genor BioPharma Co., Ltd. Company Details
Table 59. Genor BioPharma Co., Ltd. Business Overview
Table 60. Genor BioPharma Co., Ltd. Still's Disease Treatment Product
Table 61. Genor BioPharma Co., Ltd. Revenue in Still's Disease Treatment Business (2020-2025) & (US$ Million)
Table 62. Genor BioPharma Co., Ltd. Recent Development
Table 63. Hetero Drugs Limited Company Details
Table 64. Hetero Drugs Limited Business Overview
Table 65. Hetero Drugs Limited Still's Disease Treatment Product
Table 66. Hetero Drugs Limited Revenue in Still's Disease Treatment Business (2020-2025) & (US$ Million)
Table 67. Hetero Drugs Limited Recent Development
Table 68. Mabion SA Company Details
Table 69. Mabion SA Business Overview
Table 70. Mabion SA Still's Disease Treatment Product
Table 71. Mabion SA Revenue in Still's Disease Treatment Business (2020-2025) & (US$ Million)
Table 72. Mabion SA Recent Development
Table 73. Mycenax Biotech Inc. Company Details
Table 74. Mycenax Biotech Inc. Business Overview
Table 75. Mycenax Biotech Inc. Still's Disease Treatment Product
Table 76. Mycenax Biotech Inc. Revenue in Still's Disease Treatment Business (2020-2025) & (US$ Million)
Table 77. Mycenax Biotech Inc. Recent Development
Table 78. Oncobiologics, Inc. Company Details
Table 79. Oncobiologics, Inc. Business Overview
Table 80. Oncobiologics, Inc. Still's Disease Treatment Product
Table 81. Oncobiologics, Inc. Revenue in Still's Disease Treatment Business (2020-2025) & (US$ Million)
Table 82. Oncobiologics, Inc. Recent Development
Table 83. Oncodesign SA Company Details
Table 84. Oncodesign SA Business Overview
Table 85. Oncodesign SA Still's Disease Treatment Product
Table 86. Oncodesign SA Revenue in Still's Disease Treatment Business (2020-2025) & (US$ Million)
Table 87. Oncodesign SA Recent Development
Table 88. Panacea Biotec Limited Company Details
Table 89. Panacea Biotec Limited Business Overview
Table 90. Panacea Biotec Limited Still's Disease Treatment Product
Table 91. Panacea Biotec Limited Revenue in Still's Disease Treatment Business (2020-2025) & (US$ Million)
Table 92. Panacea Biotec Limited Recent Development
Table 93. Pfizer Inc. Company Details
Table 94. Pfizer Inc. Business Overview
Table 95. Pfizer Inc. Still's Disease Treatment Product
Table 96. Pfizer Inc. Revenue in Still's Disease Treatment Business (2020-2025) & (US$ Million)
Table 97. Pfizer Inc. Recent Development
Table 98. Sandoz International GmbH Company Details
Table 99. Sandoz International GmbH Business Overview
Table 100. Sandoz International GmbH Still's Disease Treatment Product
Table 101. Sandoz International GmbH Revenue in Still's Disease Treatment Business (2020-2025) & (US$ Million)
Table 102. Sandoz International GmbH Recent Development
Table 103. Swedish Orphan Biovitrum AB Company Details
Table 104. Swedish Orphan Biovitrum AB Business Overview
Table 105. Swedish Orphan Biovitrum AB Still's Disease Treatment Product
Table 106. Swedish Orphan Biovitrum AB Revenue in Still's Disease Treatment Business (2020-2025) & (US$ Million)
Table 107. Swedish Orphan Biovitrum AB Recent Development
Table 108. Therapeutic Proteins International, LLC Company Details
Table 109. Therapeutic Proteins International, LLC Business Overview
Table 110. Therapeutic Proteins International, LLC Still's Disease Treatment Product
Table 111. Therapeutic Proteins International, LLC Revenue in Still's Disease Treatment Business (2020-2025) & (US$ Million)
Table 112. Therapeutic Proteins International, LLC Recent Development
Table 113. UCB S.A. Company Details
Table 114. UCB S.A. Business Overview
Table 115. UCB S.A. Still's Disease Treatment Product
Table 116. UCB S.A. Revenue in Still's Disease Treatment Business (2020-2025) & (US$ Million)
Table 117. UCB S.A. Recent Development
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
Table 121. Authors List of This Report
List of Figures
Figure 1. Still's Disease Treatment Picture
Figure 2. Global Still's Disease Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Still's Disease Treatment Market Share by Type: 2024 VS 2031
Figure 4. Certolizumab Pegol Features
Figure 5. DNX-514 Features
Figure 6. Etanercept Features
Figure 7. Others Features
Figure 8. Global Still's Disease Treatment Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Still's Disease Treatment Market Share by Application: 2024 VS 2031
Figure 10. Clinic Case Studies
Figure 11. Hospital Case Studies
Figure 12. Others Case Studies
Figure 13. Still's Disease Treatment Report Years Considered
Figure 14. Global Still's Disease Treatment Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Still's Disease Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Still's Disease Treatment Market Share by Region: 2024 VS 2031
Figure 17. Global Still's Disease Treatment Market Share by Players in 2024
Figure 18. Global Top Still's Disease Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Still's Disease Treatment as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Still's Disease Treatment Revenue in 2024
Figure 20. North America Still's Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Still's Disease Treatment Market Share by Country (2020-2031)
Figure 22. United States Still's Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Still's Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Still's Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Still's Disease Treatment Market Share by Country (2020-2031)
Figure 26. Germany Still's Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Still's Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Still's Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Still's Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Still's Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Still's Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Still's Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Still's Disease Treatment Market Share by Region (2020-2031)
Figure 34. China Still's Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Still's Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Still's Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Still's Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Still's Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Still's Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Still's Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Still's Disease Treatment Market Share by Country (2020-2031)
Figure 42. Mexico Still's Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Still's Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Still's Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Still's Disease Treatment Market Share by Country (2020-2031)
Figure 46. Turkey Still's Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Still's Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Still's Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Biocon Limited Revenue Growth Rate in Still's Disease Treatment Business (2020-2025)
Figure 50. Epirus Biopharmaceuticals, Inc. Revenue Growth Rate in Still's Disease Treatment Business (2020-2025)
Figure 51. Genor BioPharma Co., Ltd. Revenue Growth Rate in Still's Disease Treatment Business (2020-2025)
Figure 52. Hetero Drugs Limited Revenue Growth Rate in Still's Disease Treatment Business (2020-2025)
Figure 53. Mabion SA Revenue Growth Rate in Still's Disease Treatment Business (2020-2025)
Figure 54. Mycenax Biotech Inc. Revenue Growth Rate in Still's Disease Treatment Business (2020-2025)
Figure 55. Oncobiologics, Inc. Revenue Growth Rate in Still's Disease Treatment Business (2020-2025)
Figure 56. Oncodesign SA Revenue Growth Rate in Still's Disease Treatment Business (2020-2025)
Figure 57. Panacea Biotec Limited Revenue Growth Rate in Still's Disease Treatment Business (2020-2025)
Figure 58. Pfizer Inc. Revenue Growth Rate in Still's Disease Treatment Business (2020-2025)
Figure 59. Sandoz International GmbH Revenue Growth Rate in Still's Disease Treatment Business (2020-2025)
Figure 60. Swedish Orphan Biovitrum AB Revenue Growth Rate in Still's Disease Treatment Business (2020-2025)
Figure 61. Therapeutic Proteins International, LLC Revenue Growth Rate in Still's Disease Treatment Business (2020-2025)
Figure 62. UCB S.A. Revenue Growth Rate in Still's Disease Treatment Business (2020-2025)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Table 1. Global Still's Disease Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Certolizumab Pegol
Table 3. Key Players of DNX-514
Table 4. Key Players of Etanercept
Table 5. Key Players of Others
Table 6. Global Still's Disease Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Still's Disease Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Still's Disease Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Still's Disease Treatment Market Share by Region (2020-2025)
Table 10. Global Still's Disease Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Still's Disease Treatment Market Share by Region (2026-2031)
Table 12. Still's Disease Treatment Market Trends
Table 13. Still's Disease Treatment Market Drivers
Table 14. Still's Disease Treatment Market Challenges
Table 15. Still's Disease Treatment Market Restraints
Table 16. Global Still's Disease Treatment Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Still's Disease Treatment Market Share by Players (2020-2025)
Table 18. Global Top Still's Disease Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Still's Disease Treatment as of 2024)
Table 19. Ranking of Global Top Still's Disease Treatment Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Still's Disease Treatment Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Still's Disease Treatment, Headquarters and Area Served
Table 22. Global Key Players of Still's Disease Treatment, Product and Application
Table 23. Global Key Players of Still's Disease Treatment, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Still's Disease Treatment Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Still's Disease Treatment Revenue Market Share by Type (2020-2025)
Table 27. Global Still's Disease Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Still's Disease Treatment Revenue Market Share by Type (2026-2031)
Table 29. Global Still's Disease Treatment Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Still's Disease Treatment Revenue Market Share by Application (2020-2025)
Table 31. Global Still's Disease Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Still's Disease Treatment Revenue Market Share by Application (2026-2031)
Table 33. North America Still's Disease Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Still's Disease Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Still's Disease Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Still's Disease Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Still's Disease Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Still's Disease Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Still's Disease Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Still's Disease Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Still's Disease Treatment Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Still's Disease Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Still's Disease Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Still's Disease Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Still's Disease Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Still's Disease Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Still's Disease Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 48. Biocon Limited Company Details
Table 49. Biocon Limited Business Overview
Table 50. Biocon Limited Still's Disease Treatment Product
Table 51. Biocon Limited Revenue in Still's Disease Treatment Business (2020-2025) & (US$ Million)
Table 52. Biocon Limited Recent Development
Table 53. Epirus Biopharmaceuticals, Inc. Company Details
Table 54. Epirus Biopharmaceuticals, Inc. Business Overview
Table 55. Epirus Biopharmaceuticals, Inc. Still's Disease Treatment Product
Table 56. Epirus Biopharmaceuticals, Inc. Revenue in Still's Disease Treatment Business (2020-2025) & (US$ Million)
Table 57. Epirus Biopharmaceuticals, Inc. Recent Development
Table 58. Genor BioPharma Co., Ltd. Company Details
Table 59. Genor BioPharma Co., Ltd. Business Overview
Table 60. Genor BioPharma Co., Ltd. Still's Disease Treatment Product
Table 61. Genor BioPharma Co., Ltd. Revenue in Still's Disease Treatment Business (2020-2025) & (US$ Million)
Table 62. Genor BioPharma Co., Ltd. Recent Development
Table 63. Hetero Drugs Limited Company Details
Table 64. Hetero Drugs Limited Business Overview
Table 65. Hetero Drugs Limited Still's Disease Treatment Product
Table 66. Hetero Drugs Limited Revenue in Still's Disease Treatment Business (2020-2025) & (US$ Million)
Table 67. Hetero Drugs Limited Recent Development
Table 68. Mabion SA Company Details
Table 69. Mabion SA Business Overview
Table 70. Mabion SA Still's Disease Treatment Product
Table 71. Mabion SA Revenue in Still's Disease Treatment Business (2020-2025) & (US$ Million)
Table 72. Mabion SA Recent Development
Table 73. Mycenax Biotech Inc. Company Details
Table 74. Mycenax Biotech Inc. Business Overview
Table 75. Mycenax Biotech Inc. Still's Disease Treatment Product
Table 76. Mycenax Biotech Inc. Revenue in Still's Disease Treatment Business (2020-2025) & (US$ Million)
Table 77. Mycenax Biotech Inc. Recent Development
Table 78. Oncobiologics, Inc. Company Details
Table 79. Oncobiologics, Inc. Business Overview
Table 80. Oncobiologics, Inc. Still's Disease Treatment Product
Table 81. Oncobiologics, Inc. Revenue in Still's Disease Treatment Business (2020-2025) & (US$ Million)
Table 82. Oncobiologics, Inc. Recent Development
Table 83. Oncodesign SA Company Details
Table 84. Oncodesign SA Business Overview
Table 85. Oncodesign SA Still's Disease Treatment Product
Table 86. Oncodesign SA Revenue in Still's Disease Treatment Business (2020-2025) & (US$ Million)
Table 87. Oncodesign SA Recent Development
Table 88. Panacea Biotec Limited Company Details
Table 89. Panacea Biotec Limited Business Overview
Table 90. Panacea Biotec Limited Still's Disease Treatment Product
Table 91. Panacea Biotec Limited Revenue in Still's Disease Treatment Business (2020-2025) & (US$ Million)
Table 92. Panacea Biotec Limited Recent Development
Table 93. Pfizer Inc. Company Details
Table 94. Pfizer Inc. Business Overview
Table 95. Pfizer Inc. Still's Disease Treatment Product
Table 96. Pfizer Inc. Revenue in Still's Disease Treatment Business (2020-2025) & (US$ Million)
Table 97. Pfizer Inc. Recent Development
Table 98. Sandoz International GmbH Company Details
Table 99. Sandoz International GmbH Business Overview
Table 100. Sandoz International GmbH Still's Disease Treatment Product
Table 101. Sandoz International GmbH Revenue in Still's Disease Treatment Business (2020-2025) & (US$ Million)
Table 102. Sandoz International GmbH Recent Development
Table 103. Swedish Orphan Biovitrum AB Company Details
Table 104. Swedish Orphan Biovitrum AB Business Overview
Table 105. Swedish Orphan Biovitrum AB Still's Disease Treatment Product
Table 106. Swedish Orphan Biovitrum AB Revenue in Still's Disease Treatment Business (2020-2025) & (US$ Million)
Table 107. Swedish Orphan Biovitrum AB Recent Development
Table 108. Therapeutic Proteins International, LLC Company Details
Table 109. Therapeutic Proteins International, LLC Business Overview
Table 110. Therapeutic Proteins International, LLC Still's Disease Treatment Product
Table 111. Therapeutic Proteins International, LLC Revenue in Still's Disease Treatment Business (2020-2025) & (US$ Million)
Table 112. Therapeutic Proteins International, LLC Recent Development
Table 113. UCB S.A. Company Details
Table 114. UCB S.A. Business Overview
Table 115. UCB S.A. Still's Disease Treatment Product
Table 116. UCB S.A. Revenue in Still's Disease Treatment Business (2020-2025) & (US$ Million)
Table 117. UCB S.A. Recent Development
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
Table 121. Authors List of This Report
List of Figures
Figure 1. Still's Disease Treatment Picture
Figure 2. Global Still's Disease Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Still's Disease Treatment Market Share by Type: 2024 VS 2031
Figure 4. Certolizumab Pegol Features
Figure 5. DNX-514 Features
Figure 6. Etanercept Features
Figure 7. Others Features
Figure 8. Global Still's Disease Treatment Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Still's Disease Treatment Market Share by Application: 2024 VS 2031
Figure 10. Clinic Case Studies
Figure 11. Hospital Case Studies
Figure 12. Others Case Studies
Figure 13. Still's Disease Treatment Report Years Considered
Figure 14. Global Still's Disease Treatment Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Still's Disease Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Still's Disease Treatment Market Share by Region: 2024 VS 2031
Figure 17. Global Still's Disease Treatment Market Share by Players in 2024
Figure 18. Global Top Still's Disease Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Still's Disease Treatment as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Still's Disease Treatment Revenue in 2024
Figure 20. North America Still's Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Still's Disease Treatment Market Share by Country (2020-2031)
Figure 22. United States Still's Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Still's Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Still's Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Still's Disease Treatment Market Share by Country (2020-2031)
Figure 26. Germany Still's Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Still's Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Still's Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Still's Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Still's Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Still's Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Still's Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Still's Disease Treatment Market Share by Region (2020-2031)
Figure 34. China Still's Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Still's Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Still's Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Still's Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Still's Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Still's Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Still's Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Still's Disease Treatment Market Share by Country (2020-2031)
Figure 42. Mexico Still's Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Still's Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Still's Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Still's Disease Treatment Market Share by Country (2020-2031)
Figure 46. Turkey Still's Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Still's Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Still's Disease Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Biocon Limited Revenue Growth Rate in Still's Disease Treatment Business (2020-2025)
Figure 50. Epirus Biopharmaceuticals, Inc. Revenue Growth Rate in Still's Disease Treatment Business (2020-2025)
Figure 51. Genor BioPharma Co., Ltd. Revenue Growth Rate in Still's Disease Treatment Business (2020-2025)
Figure 52. Hetero Drugs Limited Revenue Growth Rate in Still's Disease Treatment Business (2020-2025)
Figure 53. Mabion SA Revenue Growth Rate in Still's Disease Treatment Business (2020-2025)
Figure 54. Mycenax Biotech Inc. Revenue Growth Rate in Still's Disease Treatment Business (2020-2025)
Figure 55. Oncobiologics, Inc. Revenue Growth Rate in Still's Disease Treatment Business (2020-2025)
Figure 56. Oncodesign SA Revenue Growth Rate in Still's Disease Treatment Business (2020-2025)
Figure 57. Panacea Biotec Limited Revenue Growth Rate in Still's Disease Treatment Business (2020-2025)
Figure 58. Pfizer Inc. Revenue Growth Rate in Still's Disease Treatment Business (2020-2025)
Figure 59. Sandoz International GmbH Revenue Growth Rate in Still's Disease Treatment Business (2020-2025)
Figure 60. Swedish Orphan Biovitrum AB Revenue Growth Rate in Still's Disease Treatment Business (2020-2025)
Figure 61. Therapeutic Proteins International, LLC Revenue Growth Rate in Still's Disease Treatment Business (2020-2025)
Figure 62. UCB S.A. Revenue Growth Rate in Still's Disease Treatment Business (2020-2025)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Allergen Detection Market Research Report 2025
Jun 28, 25
Global Electronic Health Tracking System Market Research Report 2025
Jun 28, 25
Global Speciality Optical Fibers Market Research Report 2025
Jun 28, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232